Patient perspectives on once-weekly medications for diabetes
GLP-1RAs and Reduced Risk of Haemorrhagic Stroke The study identified more than 24,700 patients with type 2 diabetes and unruptured IAs between 2008 and 2025
Dose: 250750 mcg daily Route: SubQ injection Cycle: 24 weeks Though it does not directly increase muscle size, it reduces soreness, inflammation, and downtime after intense training
With the patent expiry of this blockbuster GLP-1 therapy, access to treatment is set to improve significantly, bringing more affordable options to patients across the country
Lancet 390(10094):613624 Lashgari NA, Momeni Roudsari N, Khayatan D, Shayan M, Momtaz S, Roufogalis BD, Abdolghaffari AH, Sahebkar A (2022) Ginger and its constituents: role in treatment of inflammatory bowel disease
They need to OPEN their gates of business flow, they need to IMPROVE their gates where business flows, and fully embrace the future of ePrescribing